Janus Henderson Group PLC Has $244.62 Million Stake in Surgery Partners, Inc. (NASDAQ:SGRY)

Janus Henderson Group PLC grew its position in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 110.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,554,845 shares of the company's stock after purchasing an additional 6,057,477 shares during the period. Janus Henderson Group PLC owned approximately 9.09% of Surgery Partners worth $244,616,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of SGRY. Franklin Resources Inc. lifted its holdings in shares of Surgery Partners by 19.5% in the third quarter. Franklin Resources Inc. now owns 21,324 shares of the company's stock valued at $677,000 after purchasing an additional 3,487 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of Surgery Partners by 3.0% in the third quarter. JPMorgan Chase & Co. now owns 189,436 shares of the company's stock valued at $6,107,000 after purchasing an additional 5,551 shares in the last quarter. Harbor Capital Advisors Inc. lifted its holdings in shares of Surgery Partners by 25.2% in the fourth quarter. Harbor Capital Advisors Inc. now owns 67,443 shares of the company's stock valued at $1,428,000 after purchasing an additional 13,588 shares in the last quarter. Inspire Investing LLC lifted its holdings in shares of Surgery Partners by 47.5% in the fourth quarter. Inspire Investing LLC now owns 19,034 shares of the company's stock valued at $403,000 after purchasing an additional 6,131 shares in the last quarter. Finally, KBC Group NV lifted its holdings in shares of Surgery Partners by 66.1% in the fourth quarter. KBC Group NV now owns 3,962 shares of the company's stock valued at $84,000 after purchasing an additional 1,577 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Royal Bank of Canada restated an "outperform" rating and issued a $35.00 price target on shares of Surgery Partners in a report on Tuesday, March 25th. Benchmark reaffirmed a "buy" rating and issued a $35.00 target price on shares of Surgery Partners in a research report on Monday, April 21st. Finally, Macquarie lowered their target price on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 11th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat.com, Surgery Partners presently has an average rating of "Moderate Buy" and an average price target of $34.75.

Surgery Partners Stock Performance

NASDAQ SGRY traded up $0.30 during trading on Friday, reaching $23.94. 962,649 shares of the company's stock were exchanged, compared to its average volume of 1,092,433. The business has a 50 day moving average price of $22.55 and a 200-day moving average price of $23.19. The stock has a market capitalization of $3.07 billion, a P/E ratio of -49.88, a PEG ratio of 19.21 and a beta of 1.96. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. Surgery Partners, Inc. has a fifty-two week low of $19.50 and a fifty-two week high of $33.97.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings results on Monday, May 12th. The company reported $0.04 earnings per share for the quarter, missing analysts' consensus estimates of $0.08 by ($0.04). The business had revenue of $776.00 million for the quarter, compared to analyst estimates of $777.77 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. Surgery Partners's quarterly revenue was up 8.2% compared to the same quarter last year. During the same period last year, the firm earned $0.10 EPS. Sell-side analysts forecast that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Insider Transactions at Surgery Partners

In related news, insider Marissa Brittenham sold 3,156 shares of the business's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $24.09, for a total value of $76,028.04. Following the completion of the sale, the insider now directly owns 63,408 shares in the company, valued at approximately $1,527,498.72. The trade was a 4.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO David T. Doherty sold 6,733 shares of the company's stock in a transaction on Monday, March 10th. The stock was sold at an average price of $24.02, for a total value of $161,726.66. Following the sale, the chief financial officer now owns 150,868 shares of the company's stock, valued at $3,623,849.36. The trade was a 4.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.30% of the company's stock.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.